Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk's Weight Loss Drug Ozempic Associated With Reduced Opioid, Alcohol Use Disorder Incidences, Study Shows
A study found that prescriptions for GIP/GLP-1 RA drugs may reduce opioid overdose and alcohol intoxication rates in patients with OUD and AUD, offering potential new treatments for addiction.
Ozempic Could Be Used to Treat Alcohol and Drug Addiction, Study Finds
In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.
Weight loss drugs like Ozempic may help reduce overdose risks: Study
A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
'Miracle' Weight Loss Drug Ozempic And Similar Drugs Reduce Alcohol And Opioid Overdose, Study Reveals
Research published in the journal Addiction indicates that GLP-1 drugs like Ozempic may play a crucial role in reducing substance abuse.
Ozempic could help with opioid and alcohol abuse, new research shows
Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.
Ozempic shows promise for treating alcohol and drug abuse, study finds
The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Ozempic and similar products cut opioid and alcohol abuse by up to half, according to research that adds to evidence of the hugely popular blockbuster drugs’ broad potential beyond tackling obesity and diabetes.
Ozempic may help battle drug and alcohol addiction
Weight-loss drugs like Ozempic and Mounjaro, which also treat diabetes, may help users battling drug and alcohol abuse as well. A study published in the Addiction medical journal Wednesday showed roughy 1.
Scientists Discover Amazing New Benefit of Ozempic: Reducing Alcohol and Opioid Addiction
New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people with substance use disorders. These medications, often prescribed for diabetes and weight issues,
4h
Judge Shuts Down Efforts to Expand Scope of Discovery in Ozempic MDL
Judge Karen Marston held that, despite plaintiffs' arguments to the contrary, marketing discovery is not relevant to the ...
tyla
4d
Doctor issues devastating warning of ‘overlooked’ side effects of using Ozempic
Wylie said: "Ozempic (semaglutide) is a medication licensed for the management of type 2 diabetes. While it has shown ...
11d
Novo Nordisk settles US patent fight with Viatris over Ozempic
Novo Nordisk and Viatris have agreed to resolve a patent dispute related to Novo's blockbuster weight-loss drugs Ozempic and ...
2d
on MSN
Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of notable wins have me thinking this lead will widen. Earli ...
eturbonews
10d
Ozempic Weight Loss Medication Warns of Life-Threatening Fraud
Losing weight with Ozempic is an expensive undertaking because Novo Nordisk, the company that produces Ozempic, monopolizes ...
11d
Mass. to play a key role as Novo Nordisk grows beyond Ozempic
Novo Nordisk says Massachusetts plays a key role in its bid to expand beyond its historic focus as a diabetes and obesity ...
FiercePharma
7h
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal
Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...
3h
on MSN
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
A coalition of unions, consumer groups, and public interest organizations has written to Lina Khan, Chair of the Federal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback